Cash was $29,346 at March 31, 2026, with management citing substantial doubt about going concern and plans to raise additional capital.
Nine-month results improve on prior gain
For the nine months ended March 31, 2026, net income turned to $861,105 from a net loss of $499,046, helped by a $1.4 million non-recurring gain on debt extinguishment recognized in the prior quarter.
Quarterly results widen loss as sales fall
America Great Health posted a net loss of $166,216 for the quarter ended March 31, 2026, widening from a net loss of $158,377 a year earlier.
Sales fell 53.44% to $26,143, citing the absence of major wholesale accounts in U.S. markets.
Operating expenses declined 28.73% to $96,308, driven by lower payroll, auditing, and professional costs.
AAGH•
